Urticarial vasculitis: a unique presentation.
Urticarial vasculitis is a relatively rare diagnosis in a patient presenting with urticaria. The process is classically described as a generalized eruption, painful more so than pruritic, lasting longer than 24 hours. Two forms of urticarial vasculitis have been described: ahypocomplementemic form more commonly associated with systemic disease, and a normocomplementemic form that is generally limited to the skin. We report on a uniquely distributed vasculitic eruption restricted mainly to the anterior belt line area in a patient presenting with urticaria and intense pruritus. Urticarial vasculitis as a unique entity is reviewed along with its clinical and histopathologic presentation and the pharmacologic agents used for treatment.
Stigall
Landon E
LE
Division of Dermatology, Department of Internal Medicine, East Tennessee State University Quillen College of Medicine, 1809 West Lakeview Drive #21, Johnson City, TN 37601, USA. lstigall2@gmail.com
Sigmon
Justin R
JR
Leicht
Stuart S
SS
D000328:Adult; D000730:Androstadienes / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068298:Fluticasone; D006801:Humans; D008297:Male; D009450:Neurodermatitis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology*; D014581:Urticaria / Q000188:drug therapy / Q000209:etiology*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy*
D000730:Androstadienes; D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone; D003078:Colchicine; D011241:Prednisone